Treatment of varicose and telangiectatic leg veins: Double-blind prospective comparative trial between aethoxyskerol and sotradecol

Dermatologic Surgery

Volumn 28, Issue 1, 2002, Pages 52-55

  Goldman, Mitchel P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Dermatology Associates of San Diego County Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL; TETRADECYL SULFATE SODIUM; TROMBOJECT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG SAFETY; ECCHYMOSIS; HUMAN; HYPERPIGMENTATION; LEG VARICOSIS; LEG VEIN; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN NECROSIS; TELANGIECTASIA; URTICARIA; VEIN THROMBOSIS;

DOUBLE-BLIND METHOD; HUMANS; LEG; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SODIUM TETRADECYL SULFATE; TELANGIECTASIS; TREATMENT OUTCOME; VARICOSE VEINS;

EID: 0036155142     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.2002.01190.x     Document Type: Article

References (18)

1. Treatment of varicose veins
2. The activity of anionic surface active compounds in producing vascular obliteration
3. Recent trends in the diagnosis and treatment of varicose veins
4. Spider angiomata: Treatment with sclerosant injections
5. Therapy for superficial telangiectasias of the lower extremities
6. Die ausschaltug sensibler nerven duren peridurale und paravertebrale injection von alkylpolyathylenoxydathern bei meerschweinchen
7. Sclerotherapy: Review of results and complications in 200 patients
8. Neuere erkenntisse zur pharmakokinetik von polidocanol (Aethoxysklerol)
9. Treatment of telangiectasia: Comparison of sclerosing agents
10. The Australian polidocanol (aethoxysklerol) study: Results at two years
11. Sclerosing agents in the treatment of telangiectasia: Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate and hypertonic saline in the dorsal rabbit ear vein model
12. Clinical trials of a new sclerosing agent: Aethoxysklerol
13. Aethoxysklerol (Kreussler) in the sclerosing treatment of varices
14. Our experience with aethoxysklerol
15. Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias
16. Small vessel sclerotherapy: An overview
17. Treatment of essential telangiectasia. Effects of increasing concentrations of polidocanol